arrow
M

Matan Thangavelu Thangavelu

agency for science technology & research (a*star)
H指数:6
被引数:416

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype

构建奥沙利铂耐药的结直肠癌模型揭示了基于SERPINE1的基因签名(RESIST-M)及促进转移的CMS4亚型的治疗策略

2025-07-160
OAAI
CAN-Scan: A multi-omic phenotype-driven precision oncology platform identifies prognostic biomarkers of therapy response for colorectal cancer

CAN-Scan:一个多组学表型驱动的精准肿瘤学平台,用于识别结直肠癌治疗反应的预后生物标志物

2025-04-010
OAAI
Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma
2021-10-143
OAAI
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC) (vol 64, 103220, 2021)
2021-04-010
OAAI
A chemical genetic screen identifies Aurora kinases as a therapeutic target in EGFR T790M negative, gefitinib-resistant head and neck squamous cell carcinoma (HNSCC)
2021-02-0113
OAAI
A high-throughput chemical genetic screen reveals SALL4-induced metabolic vulnerabilities in cancer
2020-08-150
PRE
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation

通过诱导p53乙酰化靶向158位密码子p53-mutant癌症

2020-04-2928
OAAI
New High-Throughput Screening Identifies Compounds That Reduce Viability Specifically in Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation
2019-12-0145
OAAI
Longitudinal single-cell RNA sequencing of patient-derived primary cells reveals drug-induced infidelity in stem cell hierarchy
2018-11-22112
OAAI
Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time
2017-09-0570
OAAI